Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Physicians may perform certain blood tests before or during treatment. For example, physicians frequently test for levels of lactate dehydrogenase (LDH) in the blood prior to treatment. Melanoma may be more difficult to treat in patients with elevated levels of LDH, particularly if the disease has spread to distant sites in the body. For patients with advanced-stage melanoma, physicians may perform other blood tests, including blood cell counts and blood chemistry tests. These tests help physicians see how well the bone marrow (the soft tissue in the center of most bones where blood cells are formed), liver and kidneys are functioning during treatment.